Insights Into Bionano Genomics Inc (BNGO) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Bionano Genomics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Instruments & Supplies industry. The current market capitalization of Bionano Genomics Inc is $58.52M. A total of 1.57 million shares were traded on the day, compared to an average of 1.63M shares.

In the most recent transaction, Mamuszka Hannah bought 65,789 shares of BNGO for 0.76 per share on Jun 13 ’23. After the transaction, the Director now owns 65,789 company shares. In a previous transaction on May 16 ’23, Holmlin R. Erik bought 15,000 shares at 0.64 per share. BNGO shares that President and CEO owns now total 806,474.

Among the insiders who bought shares, Stewart Christopher P. acquired of 50,000 shares on May 12 ’23 at a per-share price of $0.67. This resulted in the Chief Financial Officer holding 281,373 shares of BNGO after the transaction.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BNGO has a high of $11.80 and a low of $1.00.

As of this writing, BNGO has an earnings estimate of -$0.87 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.75 per share and a lower estimate of -$1.01. The company reported an EPS of -$1.24 in the last quarter, which was -20.40% lower than expectations of -$1.03.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BNGO’s latest balance sheet shows that the firm has $250.61M in Cash & Short Term Investments as of fiscal 2021. There were $10.70M in debt and $21.84M in liabilities at the time. Its Book Value Per Share was $2.10, while its Total Shareholder’s Equity was $337.12M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BNGO is Buy with a score of 4.50.

Most Popular

Related Posts